CAS 2089288-03-7

AZD1390

CAS : 2089288-03-7

Formule : C₂₇H₃₂FN₅O₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 477.5737

Ref: IN-DA01EO9B

azd1390

CAS : 2089288-03-7

azd1390

Degré de pureté : ≥95%

Masse moléculaire : 477.57g/mol

Ref: 54-BUP04108

AZD1390

CAS : 2089288-03-7

Formule : C₂₇H₃₂FN₅O₂

Masse moléculaire : 477.58

Ref: 4Z-K-031004

azd1390

CAS : 2089288-03-7

AZD1390: Potent ATM inhibitor (IC50: 0.78 nM), >10,000-fold selectivity vs. PIKK enzymes.

Formule : C₂₇H₃₂FN₅O₂

Degré de pureté : 97.41% - 99.72%

Couleur et forme : Solid

Masse moléculaire : 477.57

Ref: TM-T5175

AZD 1390

Produit contrôlé

CAS : 2089288-03-7

Formule : C₂₇H₃₂FN₅O₂

Couleur et forme : Neat

Masse moléculaire : 477.574

Ref: TR-A216035

AZD1390

CAS : 2089288-03-7

AZD1390 is a positron-emitting drug that can be used to study the molecular mechanisms of cancer. It binds to receptors on the surface of cells, activating cell signaling pathways, and is currently being studied for use in the treatment of squamous carcinoma. AZD1390 is able to penetrate solid tumours and it has been found to be effective against some types of cancer. The clinical studies showed that AZD1390 was safe and well-tolerated in patients with advanced cancers and that it had an acceptable side effect profile. This drug also has pharmacokinetic properties which make it suitable as a therapeutic agent.

Formule : C₂₇H₃₂FN₅O₂

Degré de pureté : Min. 95%

Masse moléculaire : 477.57 g/mol

Ref: 3D-PID28803